New asthma pill could offer hope for severe cases
NCT ID NCT07323654
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 25 times
Summary
This study tests an experimental daily pill, KT-621, in adults with moderate to severe eosinophilic asthma that is not well controlled by current inhalers. The goal is to see if the drug improves lung function and asthma control compared to a placebo. About 264 participants will take either the study drug or a placebo for several weeks, and researchers will monitor safety and effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kymera Investigative Site
RECRUITINGRedding, California, 96001, United States
-
Kymera Investigative Site
RECRUITINGUpland, California, 91786, United States
-
Kymera Investigative Site
RECRUITINGMiami, Florida, 33126, United States
-
Kymera Investigative Site
RECRUITINGMiami, Florida, 33173, United States
-
Kymera Investigative Site
RECRUITINGTampa, Florida, 33607, United States
-
Kymera Investigative Site
RECRUITINGEast Point, Georgia, 30344, United States
-
Kymera Investigative Site
RECRUITINGEdmond, Oklahoma, 73034, United States
-
Kymera Investigative Site
RECRUITINGClackamas, Oregon, 97015, United States
-
Kymera Investigative Site
RECRUITINGPittsburgh, Pennsylvania, 15241, United States
-
Kymera Investigative Site
RECRUITINGNorth Charleston, South Carolina, 29406, United States
-
Kymera Investigative Site
RECRUITINGRock Hill, South Carolina, 29732, United States
-
Kymera Investigative Site
RECRUITINGChattanooga, Tennessee, 37403, United States
-
Kymera Investigative Site
RECRUITINGMcKinney, Texas, 75069, United States
-
Kymera Investigative Site
RECRUITINGBelgrade, 11000, Serbia
-
Kymera Investigative Site
RECRUITINGKamenitz, 21204, Serbia
-
Kymera Investigative Site
RECRUITINGUžice, 31000, Serbia
-
Kymera Investigative Site
RECRUITINGBedford, MK40 2FG, United Kingdom
Conditions
Explore the condition pages connected to this study.